Latest Articles

Publication Date
Synergistic Inhibitory Effects of Tetramethylpyrazine and Evodiamine on Endometriosis Development.

Endometriosis (EMS) belongs to a gynecological disorder with inflammation and the existence of endometrial-like tissues beyond the uterus, often leading to infertility and pelvic pain. Estrogen receptor β (ERβ) is …

Published: Oct. 30, 2024, midnight
Non-Hormonal Therapy for Endometriosis Based on Angiogenesis, Oxidative Stress and Inflammation.

Endometriosis is a common gynecological disease that occurs in between 6 and 10% of women who are at reproductive maturity. The presence of endometrial tissue outside the uterine cavity is …

Published: Oct. 30, 2024, midnight
Combination therapy of Sanjie Zhentong capsules for endometriosis: Impact on hormone regulation and serum expression of FOLR1 and MSLN.

Examining the impact of Sanjie Zhentong capsules on hormone levels and serum expression of folate receptor 1 (FOLR1) and Mesothelin (MSLN) in endometriosis patients. A cohort of 150 endometriosis patients …

Published: Oct. 29, 2024, midnight
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive financial news

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive financial news

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors USA

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors USA

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan

Published: Oct. 28, 2024, 12:30 p.m.
Dissecting the cell microenvironment of ovarian endometrioma through single-cell RNA sequencing.

Ovarian endometrioma (OE), also known as "chocolate cysts," is a cystic mass that develops in the ovaries due to endometriosis and is a common gynecological condition characterized by the growth …

Published: Oct. 28, 2024, midnight
Patient-centered endometriosis care implementation at tertiary and secondary care hospitals in Indonesia.

Endometriosis has a high recurrence rate within five years (40-50 %). High recurrence remarkably reduces Health-Related Quality of Life (HRQOL). Patient-centered endometriosis care (PCEC) is a range of care that …

Published: Oct. 28, 2024, midnight
Revolutionizing endometriosis treatment: automated surgical operation through artificial intelligence and robotic vision.

Clinical limitations due to poverty significantly impact the lives and health of many individuals globally. Nevertheless, this challenge can be addressed with modern technologies, particularly through robotics and artificial intelligence. …

Published: Oct. 26, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!